Zacks Investment Research
28 Sept 2026, 19:35 UTC · 1h ago
Verdict
Headline takes no side. We score GEHC +0.60 across three claims — strongly bullish.
+0.60strongly bullish
More positive than 77% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
GE HealthCare's backlog increased $2.6 billion year over year to a record $23.9 billion.
Priced inanalysis of Q2 results reported earlier
So whatThe record 1.15X book-to-bill ratio suggests revenue growth will accelerate into 2027 as long-cycle radiology orders convert.
More positive than 93% of claims this week
Organic orders for the second quarter increased by 11.1%, the highest since the 2023 spin-off.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Priced inanalysis of Q2 results reported earlier
So whatBroad-based growth without one-time deals increases the probability of meeting the projected 7% five-year growth target.
More positive than 87% of claims this week
Pharmaceutical Diagnostics second-quarter organic revenues increased 14.6%, pushing EBIT margin to 29.6%.
Priced inanalysis of Q2 results reported earlier
So whatThe 30bps margin expansion in this segment helps offset inflationary pressures and higher input costs in other divisions.
More positive than 79% of claims this week
Which stocks this story touches
More positive than 77% of ticker scores this week
The company is described as well positioned for growth with record backlogs, organic order increases, and a 'Buy' rating, despite some macroeconomic risks.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+0.2%
Price flat so far
$66.78 vs $66.63 close before publication (Sep 25) · not market-adjusted
GEHC chart →
